> Apotex got an ultimatum from the FDA: Fix your manufacturing problems, or forget introducing new meds in the U.S. Report [1]
[1]> Teva, maker of the anesthetic propofol, has a massive recall underway following dozens of patients getting sick from two batches. Bacterial contamination is the chief suspect. Article [2]
[2]> EMCOR will provide facilities and energy management services for Patheon at the contract manufacturer's three U.S. plants in Manati and Caguas, Puerto Rico, and Cincinnati. Release [3]
> A groundbreaking ceremony took place recently for a planned 200,000-square-foot, $30-million Viva Biopharm manufacturing plant in Blaine, WA. Article [4]
> The Pharmaceutical Council of Nigeria cites an increasing rate of fake pharmaceutical products in circulation, and attributed the trend to the failure of manufacturers to conform to standards. Article [5]
Links:
[1] http://www.fiercepharma.com/story/apotex-plant-draws-fda-scrutiny/2009-07-15
[2] http://www.google.com/hostednews/ap/article/ALeqM5iMkoNA7ANMxeUu2iZ9hdf_Vr1FfQD99EITJ81
[3] http://www.bioresearchonline.com/article.mvc/Patheon-Signs-Facilities-Management-Agreement-0001?VNETCOOKIE=NO
[4] http://pharmanewslive.blogspot.com/2009/07/work-begins-on-blaine-pharmaceutical.html
[5] http://allafrica.com/stories/200907210096.html